Xeris reports second-quarter 2026 results, tightens full-year revenue guidanceAug 6Quarterly updatelevoketoconazoleXeris Biopharma Holdings, Inc.
Palvella Therapeutics adds Matthew Pauls to board of directorsJun 30PeoplePieris Pharmaceuticals, Inc.
Sign inSign in